Chronic inhalation of nebulized levalbuterol does not increase mucociliary clearance in healthy subjects. 2008

Jeffrey C Cleary, and Yauel Karmazyn, and Peter J Mogayzel, and Beth L Laube
Eudowood Division of Pediatric Respiratory Sciences, The Johns Hopkins Medical Institutions, Park 316, Baltimore, MD 21287-2533, USA.

Acute inhalations of beta 2-adrenergic receptor agonists increase mucociliary clearance (MCC). Less is known about the effect of long-term inhalations of these agents on MCC, or cough clearance (CC). We hypothesized that chronic inhalations of nebulized levalbuterol, the R-isomer of albuterol, would enhance MCC and/or CC in healthy subjects, compared to albuterol or placebo. This was a randomized, double-blind, placebo-controlled trial in ten healthy, adult subjects who inhaled nebulized levalbuterol (1.25mg), albuterol (2.5mg), or placebo for 7 days, three times daily. MCC and CC were measured 6-7h after the last dose of drug on the 7th day of treatment. These were quantified from gamma camera images of the lungs following inhalation of an aerosol containing the isotope (99m)technetium. Levalbuterol did not improve MCC or CC. MCC averaged (+/-SD) 12.3+/-8.3%, 9.2+/-4.7% and 10.0+/-9.6% with placebo, albuterol and levalbuterol, respectively. CC averaged 3.9+/-6.8%, 4.9+/-4.3% and 3.8+/-6.4% with placebo, albuterol and levalbuterol, respectively. These results indicate that chronic inhalations of nebulized levalbuterol for 1 week do not increase MCC or CC in healthy subjects, compared to albuterol or placebo.

UI MeSH Term Description Entries
D008168 Lung Either of the pair of organs occupying the cavity of the thorax that effect the aeration of the blood. Lungs
D008297 Male Males
D009079 Mucociliary Clearance A non-specific host defense mechanism that removes MUCUS and other material from the LUNGS by ciliary and secretory activity of the tracheobronchial submucosal glands. It is measured in vivo as mucus transfer, ciliary beat frequency, and clearance of radioactive tracers. Mucociliary Transport,Clearance, Mucociliary,Clearances, Mucociliary,Mucociliary Clearances,Mucociliary Transports,Transport, Mucociliary,Transports, Mucociliary
D009330 Nebulizers and Vaporizers Devices that cause a liquid or solid to be converted into an aerosol (spray) or a vapor. It is used in drug administration by inhalation, humidification of ambient air, and in certain analytical instruments. Atomizers,Inhalation Devices,Inhalators,Inhalers,Vaporizers,Nebulizers,Vaporizers and Nebulizers,Atomizer,Device, Inhalation,Devices, Inhalation,Inhalation Device,Inhalator,Inhaler,Nebulizer,Vaporizer
D004311 Double-Blind Method A method of studying a drug or procedure in which both the subjects and investigators are kept unaware of who is actually getting which specific treatment. Double-Masked Study,Double-Blind Study,Double-Masked Method,Double Blind Method,Double Blind Study,Double Masked Method,Double Masked Study,Double-Blind Methods,Double-Blind Studies,Double-Masked Methods,Double-Masked Studies,Method, Double-Blind,Method, Double-Masked,Methods, Double-Blind,Methods, Double-Masked,Studies, Double-Blind,Studies, Double-Masked,Study, Double-Blind,Study, Double-Masked
D004334 Drug Administration Schedule Time schedule for administration of a drug in order to achieve optimum effectiveness and convenience. Administration Schedule, Drug,Administration Schedules, Drug,Drug Administration Schedules,Schedule, Drug Administration,Schedules, Drug Administration
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000280 Administration, Inhalation The administration of drugs by the respiratory route. It includes insufflation into the respiratory tract. Drug Administration, Inhalation,Drug Administration, Respiratory,Drug Aerosol Therapy,Inhalation Drug Administration,Inhalation of Drugs,Respiratory Drug Administration,Aerosol Drug Therapy,Aerosol Therapy, Drug,Drug Therapy, Aerosol,Inhalation Administration,Administration, Inhalation Drug,Administration, Respiratory Drug,Therapy, Aerosol Drug,Therapy, Drug Aerosol
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

Jeffrey C Cleary, and Yauel Karmazyn, and Peter J Mogayzel, and Beth L Laube
August 1994, The European respiratory journal,
Jeffrey C Cleary, and Yauel Karmazyn, and Peter J Mogayzel, and Beth L Laube
April 1996, The European respiratory journal,
Jeffrey C Cleary, and Yauel Karmazyn, and Peter J Mogayzel, and Beth L Laube
September 2011, BMC pulmonary medicine,
Jeffrey C Cleary, and Yauel Karmazyn, and Peter J Mogayzel, and Beth L Laube
December 2022, Inflammation,
Jeffrey C Cleary, and Yauel Karmazyn, and Peter J Mogayzel, and Beth L Laube
July 1989, The American review of respiratory disease,
Jeffrey C Cleary, and Yauel Karmazyn, and Peter J Mogayzel, and Beth L Laube
January 1986, Respiration; international review of thoracic diseases,
Jeffrey C Cleary, and Yauel Karmazyn, and Peter J Mogayzel, and Beth L Laube
January 1990, La Medicina del lavoro,
Jeffrey C Cleary, and Yauel Karmazyn, and Peter J Mogayzel, and Beth L Laube
September 1991, Clinical physiology (Oxford, England),
Jeffrey C Cleary, and Yauel Karmazyn, and Peter J Mogayzel, and Beth L Laube
May 1998, Psychopharmacology,
Jeffrey C Cleary, and Yauel Karmazyn, and Peter J Mogayzel, and Beth L Laube
January 2011, American journal of rhinology & allergy,
Copied contents to your clipboard!